Correlation Between Tyra Biosciences and Sage Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tyra Biosciences and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tyra Biosciences and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tyra Biosciences and Sage Therapeutic, you can compare the effects of market volatilities on Tyra Biosciences and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tyra Biosciences with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tyra Biosciences and Sage Therapeutic.

Diversification Opportunities for Tyra Biosciences and Sage Therapeutic

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tyra and Sage is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Tyra Biosciences and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and Tyra Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tyra Biosciences are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of Tyra Biosciences i.e., Tyra Biosciences and Sage Therapeutic go up and down completely randomly.

Pair Corralation between Tyra Biosciences and Sage Therapeutic

Given the investment horizon of 90 days Tyra Biosciences is expected to under-perform the Sage Therapeutic. But the stock apears to be less risky and, when comparing its historical volatility, Tyra Biosciences is 1.48 times less risky than Sage Therapeutic. The stock trades about -0.14 of its potential returns per unit of risk. The Sage Therapeutic is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  554.00  in Sage Therapeutic on December 27, 2024 and sell it today you would earn a total of  306.00  from holding Sage Therapeutic or generate 55.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tyra Biosciences  vs.  Sage Therapeutic

 Performance 
       Timeline  
Tyra Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tyra Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sage Therapeutic 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sage Therapeutic are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Sage Therapeutic exhibited solid returns over the last few months and may actually be approaching a breakup point.

Tyra Biosciences and Sage Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tyra Biosciences and Sage Therapeutic

The main advantage of trading using opposite Tyra Biosciences and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tyra Biosciences position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.
The idea behind Tyra Biosciences and Sage Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk